We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$90.5B
AUM Growth
+$6.75B
Cap. Flow
-$1.78B
Cap. Flow %
-1.96%
Top 10 Hldgs %
8.27%
Holding
5,609
New
476
Increased
1,793
Reduced
1,541
Closed
783

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$826M
2
MSFT icon
Microsoft
MSFT
+$549M
3
PDD icon
Pinduoduo
PDD
+$305M
4
INTC icon
Intel
INTC
+$274M
5
AAPL icon
Apple
AAPL
+$266M

Sector Composition

Rank Sector Weight
1 Technology 13.32%
2 Healthcare 8.96%
3 Financials 7.81%
4 Consumer Discretionary 7.49%
5 Industrials 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COCHW icon
4551
Envoy Medical Warrant
COCHW
$538K
$4.31K ﹤0.01%
113,431
CFFSW
4552
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
$4.28K ﹤0.01%
133,333
NKGNW
4553
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
$4.25K ﹤0.01%
50,000
ENERW
4554
DELISTED
Accretion Acquisition Corp Warrant
ENERW
$4.21K ﹤0.01%
225,000
CIAN
4555
DELISTED
Cian PLC American Depositary Shares, each representing one Ordinary Share
CIAN
$4.2K ﹤0.01%
12,363
LOKM.WS
4556
DELISTED
Live Oak Mobility Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOKM.WS
$4.17K ﹤0.01%
29,757
THCPW
4557
DELISTED
Thunder Bridge Capital Partners IV, Inc. Warrant
THCPW
$4.15K ﹤0.01%
21,831
ALSAW
4558
DELISTED
Alpha Star Acquisition Corp Warrants
ALSAW
$4.13K ﹤0.01%
250,000
DUETW
4559
DELISTED
DUET Acquisition Corp. Warrant
DUETW
$4.11K ﹤0.01%
273,958
LOCL.WS
4560
DELISTED
Local Bounti Corporation Every 13 warrants will be exercisable for one share of common stock at an exercise price of $149.50 per share of common stock
LOCL.WS
$4.01K ﹤0.01%
24,333
-8,787
-27% -$1.89K
GTACW
4561
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$4K ﹤0.01%
99,999
DISAW
4562
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$4K ﹤0.01%
333,333
SUAC.WS
4563
DELISTED
ShoulderUp Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
SUAC.WS
$4K ﹤0.01%
199,999
BPACW
4564
DELISTED
Bullpen Parlay Acquisition Company Warrant
BPACW
$4K ﹤0.01%
199,999
LIONW
4565
DELISTED
Lionheart III Corp Warrant
LIONW
$3.96K ﹤0.01%
79,166
PGRWW
4566
DELISTED
Progress Acquisition Corp. Warrant
PGRWW
$3.92K ﹤0.01%
62,500
ACAQ.WS
4567
DELISTED
Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
ACAQ.WS
$3.88K ﹤0.01%
33,333
MVLAW
4568
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$3.88K ﹤0.01%
25,000
JWSM.WS
4569
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$3.87K ﹤0.01%
59,528
FAZEW
4570
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$3.84K ﹤0.01%
30,437
ABVEW
4571
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$3.75K ﹤0.01%
62,500
MSSAW
4572
DELISTED
Metal Sky Star Acquisition Corporation Warrant
MSSAW
$3.75K ﹤0.01%
150,000
CDIOW icon
4573
Cardio Diagnostics Holdings Inc Warrant
CDIOW
$762K
$3.7K ﹤0.01%
74,822
TRCA.WS
4574
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$3.65K ﹤0.01%
121,413
ZEOWW
4575
Zeo Energy Corp Warrants
ZEOWW
$160K
$3.58K ﹤0.01%
125,000

Similar funds

D.E. Shaw & Co's Q4 2022 Portfolio in Review

As of Q4 2022, D.E. Shaw & Co held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

D.E. Shaw & Co's Q4 2022 filing shows 476 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • D.E. Shaw & Co's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
  • D.E. Shaw & Co added most to Tesla in Q4 2022, an estimated $826M increase.
  • D.E. Shaw & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
  • D.E. Shaw & Co fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
  • D.E. Shaw & Co's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
  • D.E. Shaw & Co opened 476 new positions and closed 783 in Q4 2022.
  • D.E. Shaw & Co's portfolio value rose 8.1% quarter-over-quarter to $90.5B.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.